华北制药：下属公司获得《化学原料药上市申请批准通知书》

Core Viewpoint - North China Pharmaceutical announced the approval of its subsidiary Hebei Huamin Pharmaceutical's application for the marketing of the chemical raw material drug Cefotolan Pivoxil by the National Medical Products Administration [2] Group 1 - The approval notification for Cefotolan Pivoxil marks a significant milestone for the company [2] - The drug is expected to enhance the company's product portfolio and market competitiveness [2] - This development reflects the company's ongoing commitment to expanding its pharmaceutical offerings [2]